{"transactions":[{"id":857005,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Common Stock","published_at":"2026-03-06T21:14:47.000Z","date":"2026-03-05","kind":"sale","planned":false,"acquired":false,"shares":1053,"price":12.5508,"value":13215.9924,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.48 to $12.72, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,417 previously reported restricted stock units."}],"balance_after":25348,"source":{"system":"sec-edgar","filing":"0001193125-26-096553","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526096553/ownership.xml","form_type":"4"}},{"id":857004,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Common Stock","published_at":"2026-03-06T21:14:47.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":1080,"price":12.9163,"value":13949.604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.80 to $13.03, inclusive. The reporting person undertakes to provide to Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 19,417 previously reported restricted stock units."}],"balance_after":26401,"source":{"system":"sec-edgar","filing":"0001193125-26-096553","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000119312526096553/ownership.xml","form_type":"4"}},{"id":1112531,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Common Stock","published_at":"2025-06-13T20:10:51.000Z","date":"2025-06-11","kind":"sale","planned":false,"acquired":false,"shares":1643,"price":11.64,"value":19124.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares of common stock sold to satisfy tax withholding obligations in connection with the settlement of restricted stock units, pursuant to a pre-existing sell-to-cover requirement previously approved and mandated by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). Such sale was made without the exercise of any discretion by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes  24,324 previously reported restricted stock units."}],"balance_after":27481,"source":{"system":"sec-edgar","filing":"0000950170-25-086178","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025086178/ownership.xml","form_type":"4"}},{"id":1224465,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-03-05T21:21:14.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":34924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date."}],"balance_after":34924,"derivative":{"exercise_price":16.98,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":34924},"source":{"system":"sec-edgar","filing":"0000950170-25-033632","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025033632/ownership.xml","form_type":"4"}},{"id":1224464,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Common Stock","published_at":"2025-03-05T21:21:14.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":14723,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,401 previously reported restricted stock units."}],"balance_after":29124,"source":{"system":"sec-edgar","filing":"0000950170-25-033632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017025033632/ownership.xml","form_type":"4"}},{"id":1482622,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-06-12T20:35:38.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":190731,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33,103 of the stock options vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date certain service-based conditions are met (which will be met over three years) and (b) the date that the average closing price of the Company's common stock over a one-month calendar period has been equal to or great than 150% of the closing price of the Company's common stock on the grant date. The remaining 157,628 stock options vest on the third anniversary of the grant date."}],"balance_after":190731,"derivative":{"exercise_price":13.02,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":190731},"source":{"system":"sec-edgar","filing":"0000950170-24-072505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024072505/ownership.xml","form_type":"4"}},{"id":1482621,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Spine"}}],"security":"Common Stock","published_at":"2024-06-12T20:35:38.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":14401,"price":13.02,"value":187501.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date."}],"balance_after":14401,"source":{"system":"sec-edgar","filing":"0000950170-24-072505","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024072505/ownership.xml","form_type":"4"}},{"id":1863596,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2023-06-08T01:28:17.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":1099,"price":37.865,"value":41613.635,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":29225,"source":{"system":"sec-edgar","filing":"0001209191-23-035260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035260/doc4.xml","form_type":"4"}},{"id":1863595,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2023-06-08T01:28:17.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":1054,"price":38.991,"value":41096.514,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":30324,"source":{"system":"sec-edgar","filing":"0001209191-23-035260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919123035260/doc4.xml","form_type":"4"}},{"id":2139023,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-10-11T20:13:16.000Z","date":"2022-10-07","kind":"sale","acquired":false,"shares":1380,"price":58,"value":80040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022."}],"balance_after":31378,"source":{"system":"sec-edgar","filing":"0001209191-22-053275","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122053275/doc4.xml","form_type":"4"}},{"id":2238757,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T23:40:44.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":19900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":19900,"derivative":{"exercise_price":59.39,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":19900},"source":{"system":"sec-edgar","filing":"0001209191-22-035229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035229/doc4.xml","form_type":"4"}},{"id":2238756,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-06-08T23:40:44.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":7950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":32250,"source":{"system":"sec-edgar","filing":"0001209191-22-035229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035229/doc4.xml","form_type":"4"}},{"id":2238755,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-06-08T23:40:44.000Z","date":"2022-06-07","kind":"sale","acquired":false,"shares":2433,"price":62,"value":150846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":24400,"source":{"system":"sec-edgar","filing":"0001209191-22-035229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035229/doc4.xml","form_type":"4"}},{"id":2238754,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-06-08T23:40:44.000Z","date":"2022-06-06","kind":"sale","acquired":false,"shares":2817,"price":61.374,"value":172890.558,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":26833,"source":{"system":"sec-edgar","filing":"0001209191-22-035229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122035229/doc4.xml","form_type":"4"}},{"id":2290997,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-25T20:12:13.000Z","date":"2022-04-21","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-025516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025516/doc4.xml","form_type":"4"}},{"id":2290996,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-25T20:12:13.000Z","date":"2022-04-21","kind":"sale","acquired":false,"shares":9824,"price":73.254,"value":719647.296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options."}],"balance_after":29650,"source":{"system":"sec-edgar","filing":"0001209191-22-025516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025516/doc4.xml","form_type":"4"}},{"id":2290995,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-25T20:12:13.000Z","date":"2022-04-21","kind":"exercise","acquired":true,"shares":12500,"price":42.54,"value":531750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":39474,"source":{"system":"sec-edgar","filing":"0001209191-22-025516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025516/doc4.xml","form_type":"4"}},{"id":2293560,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-20","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":112500,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293559,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-19","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293558,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":137500,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293557,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-20","kind":"sale","acquired":false,"shares":9764,"price":73.99,"value":722438.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":26974,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293556,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-20","kind":"exercise","acquired":true,"shares":12500,"price":42.54,"value":531750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":36738,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293555,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-19","kind":"sale","acquired":false,"shares":9321,"price":72.25,"value":673442.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.01 to $72.55, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":24238,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293554,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-19","kind":"exercise","acquired":true,"shares":12500,"price":42.54,"value":531750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":33559,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293553,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-18","kind":"sale","acquired":false,"shares":8941,"price":73.55,"value":657610.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold by the reporting person to cover the (i) exercise price of stock options and (ii) tax obligations due upon the exercise of such stock options."}],"balance_after":21059,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2293552,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2022-04-21T00:25:08.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":12500,"price":42.54,"value":531750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-22-025120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919122025120/doc4.xml","form_type":"4"}},{"id":2640631,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2021-07-06T22:14:42.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":421,"price":59.76,"value":25158.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001209191-21-045622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121045622/doc4.xml","form_type":"4"}},{"id":2671408,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:40:50.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":17500,"derivative":{"exercise_price":60.96,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-21-040094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040094/doc4.xml","form_type":"4"}},{"id":2671407,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2021-06-12T00:40:50.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":17500,"source":{"system":"sec-edgar","filing":"0001209191-21-040094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121040094/doc4.xml","form_type":"4"}},{"id":2677110,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2021-06-08T20:16:39.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":2278,"price":60.5,"value":137819.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001209191-21-038889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121038889/doc4.xml","form_type":"4"}},{"id":2677109,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Rest of World"}}],"security":"Common Stock","published_at":"2021-06-08T20:16:39.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":1222,"price":61.037,"value":74587.214,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units."}],"balance_after":12778,"source":{"system":"sec-edgar","filing":"0001209191-21-038889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121038889/doc4.xml","form_type":"4"}},{"id":2911965,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2021-01-08T21:39:29.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":110,"price":60.81,"value":6689.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 110 shares of common stock acquired under the issuer's employee stock purchase plan in December 2020."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-21-002722","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919121002722/doc4.xml","form_type":"4"}},{"id":2977060,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-17T22:28:27.000Z","date":"2020-11-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-058818","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058818/doc4.xml","form_type":"4"}},{"id":2977059,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-11-17T22:28:27.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":21000,"price":63.51,"value":1333710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.005 to $63.990, inclusive."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-20-058818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058818/doc4.xml","form_type":"4"}},{"id":2977058,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-11-17T22:28:27.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":4000,"price":62.67,"value":250680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.000 to $62.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-20-058818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058818/doc4.xml","form_type":"4"}},{"id":2977057,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-11-17T22:28:27.000Z","date":"2020-11-13","kind":"exercise","acquired":true,"shares":25000,"price":42.54,"value":1063500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001209191-20-058818","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120058818/doc4.xml","form_type":"4"}},{"id":3025793,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-21T22:23:25.000Z","date":"2020-09-17","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-051357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051357/doc4.xml","form_type":"4"}},{"id":3025792,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-09-21T22:23:25.000Z","date":"2020-09-17","kind":"sale","acquired":false,"shares":2888,"price":60.26,"value":174030.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.180 to $60.400, inclusive."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-20-051357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051357/doc4.xml","form_type":"4"}},{"id":3025791,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-09-21T22:23:25.000Z","date":"2020-09-17","kind":"sale","acquired":false,"shares":22532,"price":59.75,"value":1346287.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.165 to $60.160, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 420 shares of common stock acquired under the issuer's employee stock purchase plan in June 2020."}],"balance_after":16888,"source":{"system":"sec-edgar","filing":"0001209191-20-051357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051357/doc4.xml","form_type":"4"}},{"id":3025790,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-09-21T22:23:25.000Z","date":"2020-09-17","kind":"exercise","acquired":true,"shares":25000,"price":42.54,"value":1063500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001209191-20-051357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120051357/doc4.xml","form_type":"4"}},{"id":3113033,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T22:31:58.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":47.65,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-20-036048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036048/doc4.xml","form_type":"4"}},{"id":3113032,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2020-06-11T22:31:58.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-20-036048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919120036048/doc4.xml","form_type":"4"}},{"id":3467416,"issuer":{"id":4928,"kind":"organization","name":"Pacira BioSciences, Inc.","symbol":"PCRX"},"owners":[{"id":62397,"kind":"person","name":"REINHARDT MAX","position":1,"cik":"0001780058","reported_name":"REINHARDT MAX","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-03T17:20:00.000Z","date":"2019-07-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":42.54,"expiration_date":"2029-07-02","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-19-040764","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1396814/000120919119040764/doc4.xml","form_type":"4"}}]}